Skip to Main Content

Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)


Diseases of the Cardiovascular System

What is the purpose of this trial?

The purpose of the study is to collect information on patients who have been diagnosed with transthyretin-associated amyloidosis who carry a mutation in the gene that could lead to this disease.

  • Trial with
    Pfizer Inc., U.S. Pharmaceuticals Group
  • Start Date
  • End Date

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC